Compare FirstEnergy Corp. (FE) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FirstEnergy Corp. vs Smith & Nephew plc — how do they compare? FirstEnergy Corp. trades at $45 (market cap $25.95B), while Smith & Nephew plc trades at $27.21 (market cap $11.10B). The key difference: FirstEnergy Corp. is far larger — about 2.3× Smith & Nephew plc's market cap, and FirstEnergy Corp. pays the higher dividend (4.15%). Which is the better fit depends on your goals — on Pluang, investors hold FirstEnergy Corp. for 71 Days and Smith & Nephew plc for 121 Days on average.
| FE | SNN | |
|---|---|---|
Market Cap | $25.95B | $11.10B |
Volume | 5,643,833 | 1,051,703 |
Sector | Utilities | Health |
52-Week High | $51.91 | $37.17 |
52-Week Low | $43.04 | $26.42 |
Typical Hold Time | 71 Days | 121 Days |
Enterprise Value | $54.87B | $14.13B |
Dividend Yield | 4.15% | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FirstEnergy (FE) trades at $44.93, up 0.79% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported Q2 2026 EPS of $0.50, slightly missing expectations, while Q1 beat estimates. Revenue grew to $15.09B in 2025 with a 6.86% net margin. Analysts maintain a Moderate Buy rating with a $52.80 price target, representing 17.5% upside. Recent news highlights the $36B Energize365 investment plan and consistent dividend payments.
FirstEnergy presents a stable utility investment with steady revenue growth and dividend yield, though elevated debt levels and inconsistent earnings performance pose risks. The stock's current valuation at 23.98 P/E appears reasonable given the utility sector's defensive characteristics. Upside potential exists if the company can consistently meet earnings expectations and execute its capital investment program effectively.
SNN trades at $27.10, near its 52-week low, with a bearish technical signal. The company reported solid fundamentals with revenue growth to $6.16B in 2025 and a net income margin of 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. Cash flow from operations remains strong at $1.29B, though net cash flow was negative $64M in 2025.
The outlook is mixed: strong profitability and innovation support long-term value, but near-term headwinds include analyst downgrades and competitive pressures. Risks involve execution challenges and market sentiment. The stock presents a cautious opportunity for value investors, balancing solid fundamentals against current bearish trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
